Ultragenyx Pharmaceutical | RARE - Stock


Ultragenyx Pharmaceutical reported $59M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
Agios Pharmaceuticals USD 35.75M 665K Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
BioCryst Pharmaceuticals USD 6.06M 71K Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Insmed USD 142.38M 9.48M Jun/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Kyowa Hakko Kirin JPY 67.44B 5.42B Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
Moderna USD 280M 134M Jun/2026
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026